世界のRho(D)免疫グロブリン市場2022年:5 ml、10 ml

◆英語タイトル:Global Rho(D) Immune Globulin Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

GlobalInfoResearchが発行した調査報告書(GIR22MY8954)◆商品コード:GIR22MY8954
◆発行会社(リサーチ会社):GlobalInfoResearch
◆発行日:2022年5月(※2025年版があります。お問い合わせください。)
◆ページ数:92
◆レポート形式:英語 / PDF
◆納品方法:Eメール(注文後2-3日)
◆調査対象地域:グローバル
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥528,960見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,220 ⇒換算¥793,440見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,057,920見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Rho(D)免疫グロブリン市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のRho(D)免疫グロブリンの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx%の成長率で成長すると予想されます。

Rho(D)免疫グロブリン市場は種類と用途によって区分されます。2017年~2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・5 ml、10 ml

用途別セグメントは次のように区分されます。
・政府機関、民間用、その他

世界のRho(D)免疫グロブリン市場の主要な市場プレーヤーは以下のとおりです。
・CSL Behring、Grіfоlѕ、Bayer、Kedrion Biopharma、Saol Therapeutics

地域別セグメントは次の地域・国をカバーします。
・北米(米国、カナダ、メキシコ)
・ヨーロッパ(ドイツ、フランス、イギリス、ロシア、イタリア)
・アジア太平洋(日本、中国、韓国、インド、東南アジア、オーストラリア)
・南アメリカ(ブラジル、アルゼンチン、コロンビア)
・中東およびアフリカ(サウジアラビア、UAE、エジプト、南アフリカ)

本調査レポートの内容は計15章あります。
・第1章では、Rho(D)免疫グロブリン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なRho(D)免疫グロブリンメーカーの企業概要、2019年~2022年までのRho(D)免疫グロブリンの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なRho(D)免疫グロブリンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年~2028年までの地域別Rho(D)免疫グロブリンの販売量、売上、成長性を示しています。
・第5、6章では、2017年~2028年までのRho(D)免疫グロブリンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年~2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年~2028年までの主要地域でのRho(D)免疫グロブリン市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびRho(D)免疫グロブリンの産業チェーンを掲載しています。
・第13、14、15章では、Rho(D)免疫グロブリンの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
・メーカー情報(企業概要、製品概要、販売量、価格、売上):CSL Behring、Grіfоlѕ、Bayer、Kedrion Biopharma、Saol Therapeutics
・メーカー別市場シェア
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年:5 ml、10 ml
・用途別分析2017年-2028年:政府機関、民間用、その他
・Rho(D)免疫グロブリンの北米市場規模2017年-2028年:アメリカ、カナダ、メキシコ
・Rho(D)免疫グロブリンのヨーロッパ市場規模2017年-2028年:ドイツ、イギリス、フランス、ロシア、イタリア
・Rho(D)免疫グロブリンのアジア市場規模2017年-2028年:中国、日本、韓国、インド、東南アジア、オーストラリア
・Rho(D)免疫グロブリンの南米市場規模2017年-2028年:ブラジル、アルゼンチン
・Rho(D)免疫グロブリンの中東・アフリカ市場規模2017年-2028年:サウジアラビア、トルコ、エジプト、南アフリカ
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Rho(D) Immune Globulin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Rho(D) Immune Globulin market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Government Institution accounting for % of the Rho(D) Immune Globulin global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While 5 ml segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Rho(D) Immune Globulin include CSL Behring, Grіfоlѕ, Bayer, Kedrion Biopharma, and Saol Therapeutics, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Rho(D) Immune Globulin market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
5 ml
10 ml
Market segment by Application can be divided into
Government Institution
Private Sector
Others
The key market players for global Rho(D) Immune Globulin market are listed below:
CSL Behring
Grіfоlѕ
Bayer
Kedrion Biopharma
Saol Therapeutics
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Rho(D) Immune Globulin product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Rho(D) Immune Globulin, with price, sales, revenue and global market share of Rho(D) Immune Globulin from 2019 to 2022.
Chapter 3, the Rho(D) Immune Globulin competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Rho(D) Immune Globulin breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Rho(D) Immune Globulin market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Rho(D) Immune Globulin.
Chapter 13, 14, and 15, to describe Rho(D) Immune Globulin sales channel, distributors, customers, research findings and conclusion, appendix and data source.

❖ レポートの目次 ❖

1 Market Overview
1.1 Rho(D) Immune Globulin Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Rho(D) Immune Globulin Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 5 ml
1.2.3 10 ml
1.3 Market Analysis by Application
1.3.1 Overview: Global Rho(D) Immune Globulin Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Government Institution
1.3.3 Private Sector
1.3.4 Others
1.4 Global Rho(D) Immune Globulin Market Size & Forecast
1.4.1 Global Rho(D) Immune Globulin Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Rho(D) Immune Globulin Sales in Volume (2017-2028)
1.4.3 Global Rho(D) Immune Globulin Price (2017-2028)
1.5 Global Rho(D) Immune Globulin Production Capacity Analysis
1.5.1 Global Rho(D) Immune Globulin Total Production Capacity (2017-2028)
1.5.2 Global Rho(D) Immune Globulin Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Rho(D) Immune Globulin Market Drivers
1.6.2 Rho(D) Immune Globulin Market Restraints
1.6.3 Rho(D) Immune Globulin Trends Analysis
2 Manufacturers Profiles
2.1 CSL Behring
2.1.1 CSL Behring Details
2.1.2 CSL Behring Major Business
2.1.3 CSL Behring Rho(D) Immune Globulin Product and Services
2.1.4 CSL Behring Rho(D) Immune Globulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Grіfоlѕ
2.2.1 Grіfоlѕ Details
2.2.2 Grіfоlѕ Major Business
2.2.3 Grіfоlѕ Rho(D) Immune Globulin Product and Services
2.2.4 Grіfоlѕ Rho(D) Immune Globulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Bayer
2.3.1 Bayer Details
2.3.2 Bayer Major Business
2.3.3 Bayer Rho(D) Immune Globulin Product and Services
2.3.4 Bayer Rho(D) Immune Globulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Kedrion Biopharma
2.4.1 Kedrion Biopharma Details
2.4.2 Kedrion Biopharma Major Business
2.4.3 Kedrion Biopharma Rho(D) Immune Globulin Product and Services
2.4.4 Kedrion Biopharma Rho(D) Immune Globulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Saol Therapeutics
2.5.1 Saol Therapeutics Details
2.5.2 Saol Therapeutics Major Business
2.5.3 Saol Therapeutics Rho(D) Immune Globulin Product and Services
2.5.4 Saol Therapeutics Rho(D) Immune Globulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Rho(D) Immune Globulin Breakdown Data by Manufacturer
3.1 Global Rho(D) Immune Globulin Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Rho(D) Immune Globulin Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Rho(D) Immune Globulin
3.4 Market Concentration Rate
3.4.1 Top 3 Rho(D) Immune Globulin Manufacturer Market Share in 2021
3.4.2 Top 6 Rho(D) Immune Globulin Manufacturer Market Share in 2021
3.5 Global Rho(D) Immune Globulin Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Rho(D) Immune Globulin Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Rho(D) Immune Globulin Market Size by Region
4.1.1 Global Rho(D) Immune Globulin Sales in Volume by Region (2017-2028)
4.1.2 Global Rho(D) Immune Globulin Revenue by Region (2017-2028)
4.2 North America Rho(D) Immune Globulin Revenue (2017-2028)
4.3 Europe Rho(D) Immune Globulin Revenue (2017-2028)
4.4 Asia-Pacific Rho(D) Immune Globulin Revenue (2017-2028)
4.5 South America Rho(D) Immune Globulin Revenue (2017-2028)
4.6 Middle East and Africa Rho(D) Immune Globulin Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Rho(D) Immune Globulin Sales in Volume by Type (2017-2028)
5.2 Global Rho(D) Immune Globulin Revenue by Type (2017-2028)
5.3 Global Rho(D) Immune Globulin Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Rho(D) Immune Globulin Sales in Volume by Application (2017-2028)
6.2 Global Rho(D) Immune Globulin Revenue by Application (2017-2028)
6.3 Global Rho(D) Immune Globulin Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Rho(D) Immune Globulin Sales by Type (2017-2028)
7.2 North America Rho(D) Immune Globulin Sales by Application (2017-2028)
7.3 North America Rho(D) Immune Globulin Market Size by Country
7.3.1 North America Rho(D) Immune Globulin Sales in Volume by Country (2017-2028)
7.3.2 North America Rho(D) Immune Globulin Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Rho(D) Immune Globulin Sales by Type (2017-2028)
8.2 Europe Rho(D) Immune Globulin Sales by Application (2017-2028)
8.3 Europe Rho(D) Immune Globulin Market Size by Country
8.3.1 Europe Rho(D) Immune Globulin Sales in Volume by Country (2017-2028)
8.3.2 Europe Rho(D) Immune Globulin Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Rho(D) Immune Globulin Sales by Type (2017-2028)
9.2 Asia-Pacific Rho(D) Immune Globulin Sales by Application (2017-2028)
9.3 Asia-Pacific Rho(D) Immune Globulin Market Size by Region
9.3.1 Asia-Pacific Rho(D) Immune Globulin Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Rho(D) Immune Globulin Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Rho(D) Immune Globulin Sales by Type (2017-2028)
10.2 South America Rho(D) Immune Globulin Sales by Application (2017-2028)
10.3 South America Rho(D) Immune Globulin Market Size by Country
10.3.1 South America Rho(D) Immune Globulin Sales in Volume by Country (2017-2028)
10.3.2 South America Rho(D) Immune Globulin Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Rho(D) Immune Globulin Sales by Type (2017-2028)
11.2 Middle East & Africa Rho(D) Immune Globulin Sales by Application (2017-2028)
11.3 Middle East & Africa Rho(D) Immune Globulin Market Size by Country
11.3.1 Middle East & Africa Rho(D) Immune Globulin Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Rho(D) Immune Globulin Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Rho(D) Immune Globulin and Key Manufacturers
12.2 Manufacturing Costs Percentage of Rho(D) Immune Globulin
12.3 Rho(D) Immune Globulin Production Process
12.4 Rho(D) Immune Globulin Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Rho(D) Immune Globulin Typical Distributors
13.3 Rho(D) Immune Globulin Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Rho(D) Immune Globulin Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Rho(D) Immune Globulin Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. CSL Behring Basic Information, Manufacturing Base and Competitors
Table 4. CSL Behring Major Business
Table 5. CSL Behring Rho(D) Immune Globulin Product and Services
Table 6. CSL Behring Rho(D) Immune Globulin Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Grіfоlѕ Basic Information, Manufacturing Base and Competitors
Table 8. Grіfоlѕ Major Business
Table 9. Grіfоlѕ Rho(D) Immune Globulin Product and Services
Table 10. Grіfоlѕ Rho(D) Immune Globulin Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Bayer Basic Information, Manufacturing Base and Competitors
Table 12. Bayer Major Business
Table 13. Bayer Rho(D) Immune Globulin Product and Services
Table 14. Bayer Rho(D) Immune Globulin Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Kedrion Biopharma Basic Information, Manufacturing Base and Competitors
Table 16. Kedrion Biopharma Major Business
Table 17. Kedrion Biopharma Rho(D) Immune Globulin Product and Services
Table 18. Kedrion Biopharma Rho(D) Immune Globulin Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Saol Therapeutics Basic Information, Manufacturing Base and Competitors
Table 20. Saol Therapeutics Major Business
Table 21. Saol Therapeutics Rho(D) Immune Globulin Product and Services
Table 22. Saol Therapeutics Rho(D) Immune Globulin Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Global Rho(D) Immune Globulin Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 24. Global Rho(D) Immune Globulin Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 25. Market Position of Manufacturers in Rho(D) Immune Globulin, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 26. Global Rho(D) Immune Globulin Production Capacity by Company, (K Units): 2020 VS 2021
Table 27. Head Office and Rho(D) Immune Globulin Production Site of Key Manufacturer
Table 28. Rho(D) Immune Globulin New Entrant and Capacity Expansion Plans
Table 29. Rho(D) Immune Globulin Mergers & Acquisitions in the Past Five Years
Table 30. Global Rho(D) Immune Globulin Sales by Region (2017-2022) & (K Units)
Table 31. Global Rho(D) Immune Globulin Sales by Region (2023-2028) & (K Units)
Table 32. Global Rho(D) Immune Globulin Revenue by Region (2017-2022) & (USD Million)
Table 33. Global Rho(D) Immune Globulin Revenue by Region (2023-2028) & (USD Million)
Table 34. Global Rho(D) Immune Globulin Sales by Type (2017-2022) & (K Units)
Table 35. Global Rho(D) Immune Globulin Sales by Type (2023-2028) & (K Units)
Table 36. Global Rho(D) Immune Globulin Revenue by Type (2017-2022) & (USD Million)
Table 37. Global Rho(D) Immune Globulin Revenue by Type (2023-2028) & (USD Million)
Table 38. Global Rho(D) Immune Globulin Price by Type (2017-2022) & (US$/Unit)
Table 39. Global Rho(D) Immune Globulin Price by Type (2023-2028) & (US$/Unit)
Table 40. Global Rho(D) Immune Globulin Sales by Application (2017-2022) & (K Units)
Table 41. Global Rho(D) Immune Globulin Sales by Application (2023-2028) & (K Units)
Table 42. Global Rho(D) Immune Globulin Revenue by Application (2017-2022) & (USD Million)
Table 43. Global Rho(D) Immune Globulin Revenue by Application (2023-2028) & (USD Million)
Table 44. Global Rho(D) Immune Globulin Price by Application (2017-2022) & (US$/Unit)
Table 45. Global Rho(D) Immune Globulin Price by Application (2023-2028) & (US$/Unit)
Table 46. North America Rho(D) Immune Globulin Sales by Country (2017-2022) & (K Units)
Table 47. North America Rho(D) Immune Globulin Sales by Country (2023-2028) & (K Units)
Table 48. North America Rho(D) Immune Globulin Revenue by Country (2017-2022) & (USD Million)
Table 49. North America Rho(D) Immune Globulin Revenue by Country (2023-2028) & (USD Million)
Table 50. North America Rho(D) Immune Globulin Sales by Type (2017-2022) & (K Units)
Table 51. North America Rho(D) Immune Globulin Sales by Type (2023-2028) & (K Units)
Table 52. North America Rho(D) Immune Globulin Sales by Application (2017-2022) & (K Units)
Table 53. North America Rho(D) Immune Globulin Sales by Application (2023-2028) & (K Units)
Table 54. Europe Rho(D) Immune Globulin Sales by Country (2017-2022) & (K Units)
Table 55. Europe Rho(D) Immune Globulin Sales by Country (2023-2028) & (K Units)
Table 56. Europe Rho(D) Immune Globulin Revenue by Country (2017-2022) & (USD Million)
Table 57. Europe Rho(D) Immune Globulin Revenue by Country (2023-2028) & (USD Million)
Table 58. Europe Rho(D) Immune Globulin Sales by Type (2017-2022) & (K Units)
Table 59. Europe Rho(D) Immune Globulin Sales by Type (2023-2028) & (K Units)
Table 60. Europe Rho(D) Immune Globulin Sales by Application (2017-2022) & (K Units)
Table 61. Europe Rho(D) Immune Globulin Sales by Application (2023-2028) & (K Units)
Table 62. Asia-Pacific Rho(D) Immune Globulin Sales by Region (2017-2022) & (K Units)
Table 63. Asia-Pacific Rho(D) Immune Globulin Sales by Region (2023-2028) & (K Units)
Table 64. Asia-Pacific Rho(D) Immune Globulin Revenue by Region (2017-2022) & (USD Million)
Table 65. Asia-Pacific Rho(D) Immune Globulin Revenue by Region (2023-2028) & (USD Million)
Table 66. Asia-Pacific Rho(D) Immune Globulin Sales by Type (2017-2022) & (K Units)
Table 67. Asia-Pacific Rho(D) Immune Globulin Sales by Type (2023-2028) & (K Units)
Table 68. Asia-Pacific Rho(D) Immune Globulin Sales by Application (2017-2022) & (K Units)
Table 69. Asia-Pacific Rho(D) Immune Globulin Sales by Application (2023-2028) & (K Units)
Table 70. South America Rho(D) Immune Globulin Sales by Country (2017-2022) & (K Units)
Table 71. South America Rho(D) Immune Globulin Sales by Country (2023-2028) & (K Units)
Table 72. South America Rho(D) Immune Globulin Revenue by Country (2017-2022) & (USD Million)
Table 73. South America Rho(D) Immune Globulin Revenue by Country (2023-2028) & (USD Million)
Table 74. South America Rho(D) Immune Globulin Sales by Type (2017-2022) & (K Units)
Table 75. South America Rho(D) Immune Globulin Sales by Type (2023-2028) & (K Units)
Table 76. South America Rho(D) Immune Globulin Sales by Application (2017-2022) & (K Units)
Table 77. South America Rho(D) Immune Globulin Sales by Application (2023-2028) & (K Units)
Table 78. Middle East & Africa Rho(D) Immune Globulin Sales by Region (2017-2022) & (K Units)
Table 79. Middle East & Africa Rho(D) Immune Globulin Sales by Region (2023-2028) & (K Units)
Table 80. Middle East & Africa Rho(D) Immune Globulin Revenue by Region (2017-2022) & (USD Million)
Table 81. Middle East & Africa Rho(D) Immune Globulin Revenue by Region (2023-2028) & (USD Million)
Table 82. Middle East & Africa Rho(D) Immune Globulin Sales by Type (2017-2022) & (K Units)
Table 83. Middle East & Africa Rho(D) Immune Globulin Sales by Type (2023-2028) & (K Units)
Table 84. Middle East & Africa Rho(D) Immune Globulin Sales by Application (2017-2022) & (K Units)
Table 85. Middle East & Africa Rho(D) Immune Globulin Sales by Application (2023-2028) & (K Units)
Table 86. Rho(D) Immune Globulin Raw Material
Table 87. Key Manufacturers of Rho(D) Immune Globulin Raw Materials
Table 88. Direct Channel Pros & Cons
Table 89. Indirect Channel Pros & Cons
Table 90. Rho(D) Immune Globulin Typical Distributors
Table 91. Rho(D) Immune Globulin Typical Customers
List of Figures
Figure 1. Rho(D) Immune Globulin Picture
Figure 2. Global Rho(D) Immune Globulin Revenue Market Share by Type in 2021
Figure 3. 5 ml
Figure 4. 10 ml
Figure 5. Global Rho(D) Immune Globulin Revenue Market Share by Application in 2021
Figure 6. Government Institution
Figure 7. Private Sector
Figure 8. Others
Figure 9. Global Rho(D) Immune Globulin Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 10. Global Rho(D) Immune Globulin Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Rho(D) Immune Globulin Sales (2017-2028) & (K Units)
Figure 12. Global Rho(D) Immune Globulin Price (2017-2028) & (US$/Unit)
Figure 13. Global Rho(D) Immune Globulin Production Capacity (2017-2028) & (K Units)
Figure 14. Global Rho(D) Immune Globulin Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Rho(D) Immune Globulin Market Drivers
Figure 16. Rho(D) Immune Globulin Market Restraints
Figure 17. Rho(D) Immune Globulin Market Trends
Figure 18. Global Rho(D) Immune Globulin Sales Market Share by Manufacturer in 2021
Figure 19. Global Rho(D) Immune Globulin Revenue Market Share by Manufacturer in 2021
Figure 20. Rho(D) Immune Globulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Rho(D) Immune Globulin Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Rho(D) Immune Globulin Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Rho(D) Immune Globulin Sales Market Share by Region (2017-2028)
Figure 24. Global Rho(D) Immune Globulin Revenue Market Share by Region (2017-2028)
Figure 25. North America Rho(D) Immune Globulin Revenue (2017-2028) & (USD Million)
Figure 26. Europe Rho(D) Immune Globulin Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Rho(D) Immune Globulin Revenue (2017-2028) & (USD Million)
Figure 28. South America Rho(D) Immune Globulin Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Rho(D) Immune Globulin Revenue (2017-2028) & (USD Million)
Figure 30. Global Rho(D) Immune Globulin Sales Market Share by Type (2017-2028)
Figure 31. Global Rho(D) Immune Globulin Revenue Market Share by Type (2017-2028)
Figure 32. Global Rho(D) Immune Globulin Price by Type (2017-2028) & (US$/Unit)
Figure 33. Global Rho(D) Immune Globulin Sales Market Share by Application (2017-2028)
Figure 34. Global Rho(D) Immune Globulin Revenue Market Share by Application (2017-2028)
Figure 35. Global Rho(D) Immune Globulin Price by Application (2017-2028) & (US$/Unit)
Figure 36. North America Rho(D) Immune Globulin Sales Market Share by Type (2017-2028)
Figure 37. North America Rho(D) Immune Globulin Sales Market Share by Application (2017-2028)
Figure 38. North America Rho(D) Immune Globulin Sales Market Share by Country (2017-2028)
Figure 39. North America Rho(D) Immune Globulin Revenue Market Share by Country (2017-2028)
Figure 40. United States Rho(D) Immune Globulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Rho(D) Immune Globulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Rho(D) Immune Globulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Rho(D) Immune Globulin Sales Market Share by Type (2017-2028)
Figure 44. Europe Rho(D) Immune Globulin Sales Market Share by Application (2017-2028)
Figure 45. Europe Rho(D) Immune Globulin Sales Market Share by Country (2017-2028)
Figure 46. Europe Rho(D) Immune Globulin Revenue Market Share by Country (2017-2028)
Figure 47. Germany Rho(D) Immune Globulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Rho(D) Immune Globulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Rho(D) Immune Globulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Rho(D) Immune Globulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Rho(D) Immune Globulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Rho(D) Immune Globulin Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Rho(D) Immune Globulin Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Rho(D) Immune Globulin Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Rho(D) Immune Globulin Revenue Market Share by Region (2017-2028)
Figure 56. China Rho(D) Immune Globulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Rho(D) Immune Globulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Rho(D) Immune Globulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Rho(D) Immune Globulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Rho(D) Immune Globulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Rho(D) Immune Globulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Rho(D) Immune Globulin Sales Market Share by Type (2017-2028)
Figure 63. South America Rho(D) Immune Globulin Sales Market Share by Application (2017-2028)
Figure 64. South America Rho(D) Immune Globulin Sales Market Share by Country (2017-2028)
Figure 65. South America Rho(D) Immune Globulin Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Rho(D) Immune Globulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Rho(D) Immune Globulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Rho(D) Immune Globulin Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Rho(D) Immune Globulin Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Rho(D) Immune Globulin Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Rho(D) Immune Globulin Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Rho(D) Immune Globulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Rho(D) Immune Globulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Rho(D) Immune Globulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Rho(D) Immune Globulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Rho(D) Immune Globulin in 2021
Figure 77. Manufacturing Process Analysis of Rho(D) Immune Globulin
Figure 78. Rho(D) Immune Globulin Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のRho(D)免疫グロブリン市場2022年:5 ml、10 ml(Global Rho(D) Immune Globulin Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。